Results 241 to 250 of about 195,924 (307)

Predictive factors for histological response to neoadjuvant therapy in gastric adenocarcinomas. [PDF]

Arq Bras Cir Dig
Bacha D, Boudrigua N, Mallek I, Chammem S, Attia M, Gharbi L, Lahmar A, Ben-Slama S.   +7 more
europepmc   +1 more source

Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives

Precision Medical Sciences, EarlyView.
Graphical abstract represents the risk factors for lung cancer, TCM efficacy and clinical outcomes to future challenges. Abstract Lung cancer remains a leading cause of global cancer mortality. Despite advances in conventional treatments such as surgery, chemotherapy, targeted therapy, and immunotherapy, challenges including drug resistance, toxicity ...
Zhangdeng Chen, Liujun Bao
wiley   +1 more source

Total neoadjuvant therapy for locally advanced rectal cancer: barriers to implementation in real-world practice. [PDF]

J Cancer Res Clin Oncol
Steike DR, Pepper NB, Gravemeyer S, Bremer A, Glasbrenner B, Brüwer M, Pascher A, Domagk D, Biermann L, Lenz P, Eich HT, Reinartz G.   +11 more
europepmc   +1 more source

A new perspective on cancer treatment: the interaction and application prospect between ICIs and radiotherapy

Precision Radiation Oncology, EarlyView.
The combination of immune checkpoint inhibitors (ICIs) and radiotherapy synergistically enhances efficacy through an “antigen release‐immune activation” closed‐loop mechanism, significantly improving outcomes in solid tumors (e.g., lung cancer, melanoma).
Guiling Song, Lei Wang, Guopeng Zhao, Song Tan, Xin Liu, Xinghua Li   +5 more
wiley   +1 more source

Elastography and MRI for the Evaluation of Complete Response to Neoadjuvant Therapy for Breast Cancer. [PDF]

Radiol Imaging Cancer
Horvat JV, Fazzio RT.
europepmc   +1 more source

Technical development in high‐intensity focused ultrasound for localized prostate cancer: Intraoperative compression of the prostate

UroPrecision, EarlyView.
Abstract High‐intensity focused ultrasound (HIFU) has emerged as a widely adopted, minimally invasive treatment for localized prostate cancer (PC). Although originally applied for whole‐gland treatment, recent advancements in imaging and technology have facilitated the adoption of HIFU as a focal therapy modality, targeting clinically significant ...
Sunao Shoji, Satoshi Kuroda, Airi Ichige, Naoko Matsumoto, Kumpei Takahashi, Tatsuya Otaki, Nobuyuki Nakajima, Yoshiaki Kawamura   +7 more
wiley   +1 more source

Study protocol: A randomized controlled trial of chemoradiotherapy versus chemotherapy as neoadjuvant therapy for resectable pancreatic cancer (CSGO-HBP-027). [PDF]

PLoS One
Tomimaru Y, Akita H, Tamari K, Maeda S, Wada H, Iwagami Y, Koga C, Hama N, Tomokuni A, Kobayashi S, Asaoka T, Tsujie M, Tanemura M, Murakami M, Katsura Y, Shimizu J, Yamashita M, Sakamoto S, Okamura S, Yamada T, Doki Y, Eguchi H.   +21 more
europepmc   +1 more source

Liquid biopsy in genitourinary oncology: Current clinical applications and future prospects across prostate, bladder, and renal cancers

UroPrecision, EarlyView.
Abstract Liquid biopsy has emerged as a transformative approach in oncology, providing minimally invasive access to tumor‐derived biomarkers with applications across diagnosis, prognosis, therapeutic guidance, and disease monitoring. This literature review synthesizes evidence from 125 studies evaluating circulating tumor DNA, circulating tumor cells ...
Kirolos Eskandar
wiley   +1 more source